Abstract
Topiramate is an antiepileptic drug with a beneficial clinical effect on various seizure types. Topiramate does not seem to be associated with serious adverse effects and is also well tolerated in pediatric patients. Only few cases of hypohidrosis have been described. This report presents one young patient with complex partial seizures who was medicated with topiramate when she developed fatigue, headache, intermittent hyperthermia, inability to produce sweat secretion, and dryness of the skin. Reduced sweat response was determined using the Wescor Macroduct collection procedure. Topiramate was discontinued, and within 3 weeks a repeat sweat test was completely normal. At that time, clinical signs had also disappeared. Hypohidrosis is an uncommon and reversible side effect reported in association with topiramate therapy. It is rare in patients on monotherapy. Although a definite causal relationship still needs to be established, this side effect might be attributed to an autonomic dysfunction by inhibition of isoenzymes of carbonic anhydrase localized in human eccrine sweat glands.
References
Jun 1, 1987·The Histochemical Journal·H TainioL Rechardt
Apr 1, 1989·Journal of the American Academy of Dermatology·K SatoK T Sato
Jun 1, 1993·Acta Physiologica Scandinavica·M PasternackK Kaila
May 5, 1999·Neurology·V BitonG Pledger
Apr 18, 2000·Epilepsia·R P ShankB E Maryanoff
Mar 15, 2001·Epilepsy Research·G CoppolaA Pascotto
Dec 12, 2001·Epilepsia·J ArcasV López-Martín
May 29, 2003·Pediatric Neurology·James F KnudsenJudith A Racoosin
Citations
Aug 19, 2007·Indian Journal of Pediatrics·Eva L W Fung, Edmund A S Nelson
Jan 3, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Steven C Schachter
Dec 4, 2008·Clinical Neuropharmacology·Lucia MargariMarina de Tommaso
Sep 16, 2008·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Vassiliki SirrouElisabeth Chroni
Mar 3, 2010·CNS Drugs·Dean P Sarco, Blaise F D Bourgeois
May 16, 2013·CNS Drugs·Athanasios Gaitatzis, Josemir W Sander
Dec 3, 2013·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·M Rosich Del CachoC López-Menchero Oliva
May 25, 2007·Life Sciences·Lei MaGang Zhao
Feb 26, 2016·CNS Drugs·Eman BahraniJoseph S Kass
May 23, 2007·Basic & Clinical Pharmacology & Toxicology·Jiyu TianJingchun Wang
May 17, 2008·CNS Neuroscience & Therapeutics·Richard P Shank, Bruce E Maryanoff
Apr 15, 2016·Journal of Medical Case Reports·Lucie CanelMathieu Nendaz
Apr 9, 2008·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·T BoussemartJ-M Bonardi
Jun 7, 2013·Continuum : Lifelong Learning in Neurology·L James Willmore
Sep 7, 2018·BMJ Case Reports·Roopa SiddaiahGavin Graff
Aug 11, 2018·Journal of Addiction Medicine·Ajay ManhapraAlbert J Arias
Jan 26, 2008·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·William P Cheshire, Robert D Fealey
Mar 20, 2010·Headache·Shira Y MarkowitzBrian M Grosberg
Oct 16, 2019·Journal of the American Academy of Dermatology·Jordan RosenGil Yosipovitch
Feb 5, 2021·International Journal of Women's Dermatology·Mary L Williams
Jan 18, 2021·The Journal of Dermatology·Kenji SanoRyuhei Okuyama
Feb 17, 2021·CNS Drugs·Mikail NourredineBenjamin Rolland
Oct 24, 2007·Emergency Medicine Clinics of North America·Michelle D Blumstein, Marla J Friedman